Alberico L. Catapano[au] - Search Results

Year	Number of Results
2002	2
2003	6
2004	4
2005	6
2006	11
2007	11
2008	6
2009	7
2010	11
2011	15
2012	18
2013	28
2014	27
2015	24
2016	28
2017	33
2018	30
2019	30
2020	47
2021	36
2022	45
2023	34
2024	25
2025	46
2026	6

1

Observational, Multicenter study on long-term Effectiveness and tolerability of aliROcumab (OMERO): an Italian real-life experience.

Catapano AL, Maggioni AP, Rossi F, Consolo E, Notarianni L, Agnelli G; OMERO study group. Catapano AL, et al. Int J Cardiol Cardiovasc Risk Prev. 2025 Dec 4;28:200549. doi: 10.1016/j.ijcrp.2025.200549. eCollection 2026 Mar. Int J Cardiol Cardiovasc Risk Prev. 2025. PMID: 41497741 Free PMC article.

2

Sustainable and Effective Lipid-Lowering Management: Prevention Strategies from the BRING-UP Prevention Study.

Colivicchi F, Temporelli PL, Fattirolli F, Abrignani MG, Alonzo A, Arca M, Averna M, Bertoli D, Calabrò P, Calò L, Carugo S, Catapano AL, Ceseri M, Di Fusco SA, Di Lenarda A, Fabbri G, Gulizia MM, La Rosa G, Lucci D, Maffei S, Navazio A, Oliva F, Orso F, Riccio C, Scelza N, Gabrielli D, Maggioni AP; BRING-UP Prevention. Colivicchi F, et al. Eur Heart J Qual Care Clin Outcomes. 2026 Feb 8:qcag021. doi: 10.1093/ehjqcco/qcag021. Online ahead of print. Eur Heart J Qual Care Clin Outcomes. 2026. PMID: 41655227

3

Lipid-lowering therapy and LDL cholesterol control among high- and very high-risk patients in Portugal: An analysis of the SANTORINI study.

Aguiar C, Aguiar P, Sequeira Duarte J, Gil V, Mimoso J, Monteiro P, Pinto FJ, Pinto F, Raposo J, von Hafe P, Ruivo JA, Teixeira C, Catapano AL, Ray KK. Aguiar C, et al. Among authors: catapano al. Rev Port Cardiol. 2026 Feb;45(2):51-64. doi: 10.1016/j.repc.2025.10.003. Epub 2025 Nov 28. Rev Port Cardiol. 2026. PMID: 41319792 Free article. English, Portuguese.

4

PORTRAIT Survey: Patient-Centered Overview Related to Treatment Practices in Lipoprotein Apheresis: Italian Investigating Trajectories.

Sbrana F, Dal Pino B, Corciulo C, Bigazzi F, Casula M, Catapano AL, Medde P, Sampietro T, Zenti MG; GILA Study Collaborators. Sbrana F, et al. Among authors: catapano al. Ther Apher Dial. 2026 Feb;30(1):85-89. doi: 10.1111/1744-9987.70096. Epub 2025 Nov 20. Ther Apher Dial. 2026. PMID: 41263326

5

Challenges in achieving LDL-C goals: Insights from the Italian SANTORINI study cohort.

Arca M, Calabrò P, Solini A, Pirillo A, Gambacurta R, Ray KK, Catapano AL; SANTORINI Italian Group. Arca M, et al. Among authors: catapano al. Nutr Metab Cardiovasc Dis. 2026 Feb;36(2):104412. doi: 10.1016/j.numecd.2025.104412. Epub 2025 Oct 14. Nutr Metab Cardiovasc Dis. 2026. PMID: 41125511

6

Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical Trial.

Ballantyne CM, Gellis L, Tardif JC, Banka P, Navar AM, Asprusten EA, Scott R, Stroes ESG, Froman S, Mendizabal G, Wang F, Catapano AL. Ballantyne CM, et al. Among authors: catapano al. JAMA. 2026 Jan 13;335(2):129-139. doi: 10.1001/jama.2025.20620. JAMA. 2026. PMID: 41206969 Clinical Trial.

7

Fibrates : Do They Still Have a Role in Therapy in 2025?

Pirillo A, Zambon A, Catapano AL. Pirillo A, et al. Among authors: catapano al. Curr Atheroscler Rep. 2025 Dec 26;28(1):4. doi: 10.1007/s11883-025-01379-8. Curr Atheroscler Rep. 2025. PMID: 41452383 Review.

8

Concept and practice in the use of high-dose eicosapentaenoic acid for cardiovascular disease prevention in hypertriglyceridaemia.

Roger G, Packard CJ, Masana L, Laufs U, Catapano AL, Steg PG. Roger G, et al. Among authors: catapano al. Heart. 2025 Dec 24;112(2):86-94. doi: 10.1136/heartjnl-2025-325765. Heart. 2025. PMID: 40348413 Free PMC article. Review.

9

Oral triple combination lipid-lowering therapy and LDL cholesterol goal attainment: A simulation using the SANTORINI study cohort.

Katzmann JL, Ray KK, Lee B, Becker C, Articus K, Catapano AL, Laufs U. Katzmann JL, et al. Among authors: catapano al. Eur J Prev Cardiol. 2025 Dec 23:zwaf777. doi: 10.1093/eurjpc/zwaf777. Online ahead of print. Eur J Prev Cardiol. 2025. PMID: 41436023 No abstract available.

10

Cardiovascular Prevention in Children, Adolescents, and Young Adults. A Call-to-Action of the Italian Societies of Pediatrics (SIP), Hypertension (SIIA), Study of Atherosclerosis (SISA), and Cardiovascular Prevention (SIPREC).

Genovesi S, Volpe R, Agnoletti D, Bellone S, Bona G, Casula M, Gentile L, Saladini F, Agostiniani R, Virdis A, Catapano AL, Volpe M, Giussani M. Genovesi S, et al. Among authors: catapano al. High Blood Press Cardiovasc Prev. 2025 Dec 9. doi: 10.1007/s40292-025-00773-2. Online ahead of print. High Blood Press Cardiovasc Prev. 2025. PMID: 41366616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

497 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

497 results

Results by year